Clinical Trial Update: Intermediate Expanded Access Protocol CNMAu8.EAP03

View source ↗

Summary

Clene Nanomedicine's intermediate expanded access protocol CNMAu8.EAP03 for CNM-Au8 in multiple sclerosis is temporarily not available. No current enrollment is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• CNM-Au8 (CNM-Au8)

Snippet

Sponsor: Clene Nanomedicine | Conditions: Multiple Sclerosis | Status: TEMPORARILY_NOT_AVAILABLE